PRAXIS PRECISION MEDICINES I (PRAX) Stock Income Statement
NASDAQ:PRAX - Nasdaq - US74006W2070 - Common Stock - Currency: USD
| TTM (2025-3-31) | 2024 (2024-12-31) | 2023 (2023-12-31) | 2022 (2022-12-31) | 2021 (2021-12-31) | ||||
|---|---|---|---|---|---|---|---|---|
| Revenue | 8.12M | 8.55M | 2.45M | 0.00 | 0.00 | |||
| Operating Expenses | 241.13M | 208.72M | 128.82M | 213.99M | 167.33M | |||
| Research and Development | 186.24M | 152.41M | 86.77M | 154.44M | 120.26M | |||
| Selling, General, and Administrative Expenses | 54.89M | 56.30M | 42.05M | 59.55M | 47.08M | |||
| Operating Income | -233.01M | -200.16M | -126.37M | -213.99M | -167.33M | |||
| Interest Income/Expense | 20.45M | 17.35M | 3.10M | 960.00K | 270.00K | |||
| Other Income/Expense | N/A | N/A | N/A | N/A | N/A | |||
| Non Recurring Items | N/A | N/A | N/A | -1.00M | N/A | |||
| Income Before Taxes | -212.56M | -182.82M | -123.28M | -214.03M | -167.06M | |||
| Income Tax | N/A | N/A | N/A | N/A | 0.00 | |||
| Net Income | -212.56M | -182.82M | -123.28M | -214.03M | -167.06M | |||
| EBITDA | -232.71M | -199.81M | -125.94M | -213.57M | -167.15M | |||
| Per Share Data | ||||||||
| EPS Diluted Total Ops | -10.71 | -10.21 | -18.69 | -4.64 | -3.94 | |||
| Non GAAP EPS | -10.72 | -10.27 | -23.67 | -16.84 | -3.89 | |||
| Statistics | ||||||||
| Profit Margin | -2617.11% | -2137.48% | -5037.88% | N/A | N/A | |||
| Operating Profit Margin | -2868.84% | -2340.29% | -5164.41% | N/A | N/A | |||
All data in USD